Ratings for the strength of the recommendations (Strong, Fair, Weak, Consensus, Insufficient Evidence), conclusion grades (I-V), and statement labels (Conditional versus Imperative) are defined at the end of the "Major Recommendations" field.
Chronic Kidney Disease (CKD) Medical Nutrition Therapy (Non-Dialysis)
CKD: Medical Nutrition Therapy
Medical nutrition therapy (MNT) provided by a registered dietitian (RD) is recommended for individuals with chronic kidney disease (CKD, Stages One to Five including post-kidney transplant). MNT prevents and treats protein-energy malnutrition and mineral and electrolyte disorders and minimizes the impact of other comorbidities on the progression of kidney disease (e.g., diabetes, obesity, hypertension and disorders of lipid metabolism). Studies regarding effectiveness of MNT report significant improvements in anthropometric and biochemical measurements sustained for at least one year.
Strong, Imperative
CKD: Initiation of Medical Nutrition Therapy
Referral for MNT per federal or state guidelines should be initiated at diagnosis of CKD, in order to maintain adequate nutritional status, prevent disease progression and delay renal replacement therapy (RRT). MNT should be initiated at least 12 months prior to the anticipation of RRT (dialysis or transplant).
Strong, Imperative
CKD: Frequency of Medical Nutrition Therapy
Depending on the care setting and the initiation of MNT, the RD should monitor the nutritional status of individuals with CKD every one to three months and more frequently if there is inadequate nutrient intake, protein-energy malnutrition, mineral and electrolyte disorders or the presence of an illness that may worsen nutritional status, as these are predictive of increased mortality risk. Research related to the time requirements for MNT provided by an RD indicate that approximately two hours per month for up to one year may be required to provide an effective intervention for adults with CKD.
Strong, Conditional
Recommendation Strength Rationale
- Conclusion statements were Grade I.
- The American Dietetic Association (ADA) CKD Expert Work Group concurs with the National Kidney Foundation Kidney Disease Outcome Quality Initiative (NKF KDOQI) Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. KDOQI group members accepted the guideline statements as valid if the median panel rating was seven or greater on a scale of one to nine.
CKD Assessment of Food/Nutrition-Related History
CKD: Initial Assessment of Food/Nutrition-Related History
The registered dietitian should assess the food- and nutrition-related history of adults with chronic kidney disease (including post kidney transplant), including but not limited to the following:
- Food and nutrient intake (e.g., diet history, diet experience and intake of macronutrients [and micronutrients, such as energy, protein, sodium, potassium, calcium, phosphorus, and others], as appropriate)
- Medication (prescription and over-the-counter), dietary supplements (vitamin, minerals, protein, etc.), herbal or botanical supplement use
- Knowledge, beliefs or attitudes (e.g., readiness to change nutrition and lifestyle behaviors)
- Behavior
- Factors affecting access to food and food and nutrition-related supplies (e.g., safe food and meal availability)
Assessment of the above factors is needed to effectively determine nutrition diagnoses and plan the nutrition interventions. Inability to achieve optimal nutrient intake may contribute to poor outcomes.
Consensus, Imperative
CKD: Reassessment of Food/Nutrition-Related History
On subsequent visits, the RD should reassess the food- or nutrition-related history of adults with CKD (including post kidney transplant), related to changes in other assessment parameters (laboratory and anthropometric changes), including but not limited to the following:
- Food and nutrient intake, targeted to changes in biochemical parameters
- Medication, dietary supplements, herbal or botanical supplement use
- Knowledge, beliefs or attitudes
- Behavior
- Factors affecting access to food and food and nutrition-related supplies
Assessment of the above factors is needed to explain changes in the other assessment parameters and plan additional nutrition interventions. Inability to achieve optimal nutrient intake may contribute to poor outcomes.
Consensus, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.
CKD Anthropometric Assessment Options
CKD: Use Clinical Judgment in Assessing Body Weight
Due to the absence of standard reference norms in the chronic kidney disease population (CKD, including post kidney transplant), the registered dietitian should use clinical judgment to determine which data to include in estimations of body weight:
- Actual measured weight
- History of weight changes (both long-term and recent)
- Serial weight measurements, monitored longitudinally
- Adjustments for suspected impact of edema, ascites and polycystic organs
Body weight estimates are used for calculation of nutritional needs, such as protein and energy requirements. Body weight can be difficult to determine because as kidney function declines, the ability to regulate fluid balance may be compromised and multiple factors must be considered.
Consensus, Imperative
CKD: Use Published Weight Norms with Caution
The RD may use other published weight norms in the anthropometric assessment of individuals with CKD (including post kidney transplant), but each norm has significant drawbacks and must be used with caution:
- Ideal body weight (IBW) is the body weight associated with the lowest mortality for a given height, age, sex and frame size and is based on the Metropolitan Life Insurance Height and Weight Tables. (Caution: Not generalizable to the CKD population and data-gathering methods were not standardized.)
- Hamwi Method determines the optimal body weight. (Caution: A quick and easy method for determining optimal body weight, but has no scientific data to support its use.)
- Standard Body Weight, National Health and Nutrition Examination Survey (NHANES II) (SBW as per KDOQI Nutrition Practice Guidelines) describes the median body weight of average Americans from 1976 to 1980 for height, age, sex and frame size. (Caution: Although data is validated and standardized and uses a large database of ethnically-diverse groups, data is provided only on what individuals weigh, not what they should weigh in order to reduce morbidity and mortality.)
- Body Mass Index (BMI) often defines generalized obesity and CKD research, specific to dialysis patients, has identified that patients at higher BMIs have a lower mortality risk. (Caution: The researchers may not have statistically adjusted for all confounders related to comorbid conditions occurring in CKD on dialysis [diabetes, malignancy, etc.] and it is unclear how it may relate to CKD patients not on dialysis.)
- Adjusted Body Weight (ABW) is based on the theory that 25% of the excess body weight (adipose tissue) in obese patients is metabolically active tissue. KDOQI supports the concept of subtracting 25% for obese patients and adding 25% for underweight patients. (Caution: This has not been validated for use in CKD and may either overestimate or underestimate energy and protein requirements.)
Body weight estimates are used for calculation of nutritional needs, such as protein and energy requirements. Body weight can be difficult to determine because as kidney function declines, the ability to regulate fluid balance may be compromised and multiple factors must be considered.
Consensus, Conditional
CKD: Assessment of Body Composition
The RD should assess the body composition of individuals with CKD (including post kidney transplant). Studies suggest that CKD patients exhibit altered body composition, as compared to healthy individuals.
Fair, Imperative
CKD: Methodologies for Body Composition Assessment
When assessing the body composition of individuals with CKD (including post kidney transplant), the RD may use any valid measurement methodology, such as anthropometrics (including waist circumference and body mass index) and body compartment estimates. Currently, there is no reference standard for assessing body composition in CKD patients and studies do not show that any one test is superior to another in assessing body composition among CKD patients.
Fair, Imperative
Recommendation Strength Rationale
- Conclusion statement was Grade II.
- The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.
CKD Assessment of Biochemical Parameters
CKD: Assess Biochemical Parameters
The RD should assess various biochemical parameters in adults with chronic kidney disease (including post-kidney transplant), related to:
- Glycemic control
- Protein-energy malnutrition
- Inflammation
- Kidney function
- Mineral and bone disorders
- Anemia
- Dyslipidemia
- Electrolyte disorders
- Others as appropriate
Assessment of the above factors is needed to effectively determine the nutrition diagnoses and nutrition prescription in adults with CKD and post-kidney transplant.
Consensus, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for:
- Nutrition in Chronic Renal Failure
- Bone Metabolism and Disease in Chronic Kidney Disease
- Anemia in Chronic Kidney Disease
CKD Assess CKD-Mineral and Bone Disorders
CKD: Assess CKD-Mineral and Bone Disorders
The RD should assess measurements of mineral and bone disorders (MBD) in adults with chronic kidney disease (including post kidney transplant) for prevention and treatment. Adults with CKD have altered mineral-bone metabolism and increased risk of vascular disease.
Consensus, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease.
CKD Assessment of Medical/Health History
CKD: Assessment of Medical/Health History
When implementing MNT, the RD should assess the medical and health history of individuals with CKD (including post kidney transplant) for the presence of other disease states and conditions, such as diabetes, hypertension, obesity and disorders of lipid metabolism. Adults with CKD, including post kidney transplant, have a higher prevalence of comorbidities, which are risk factors for the progression of kidney disease.
Strong, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for:
- Hypertension and Antihypertensive Agents in Chronic Kidney Disease
- Managing Dyslipidemias in Chronic Kidney Disease
- Diabetes and Chronic Kidney Disease
CKD Protein Intake
CKD: Protein Intake for Estimated Glomerular Filtration Rate (eGFR) <50 ml per minute per 1.73m2
For adults with CKD without diabetes, not on dialysis, with eGFR below 50ml per minute per 1.73m2, the RD should recommend or prescribe a protein-controlled diet providing 0.6 g to 0.8 g dietary protein per kg of body weight per day. Clinical judgment should be used when recommending lower protein intakes, considering the client's level of motivation, willingness to participate in frequent follow-up and risk for protein-energy malnutrition. Research reports that protein-restricted diets (0.7 g dietary protein per kg of body weight per day, ensuring adequate caloric intake) can slow GFR decline and maintain stable nutrition status in adult non-diabetic patients with CKD.
Strong, Conditional
CKD: Very-Low-Protein Intake for eGFR <20 ml per minute per 1.73m2
In international settings where keto acid analogs are available, a very-low protein-controlled diet may be considered. For adults with CKD without diabetes, not on dialysis, with an eGFR below 20 ml per minute per 1.73m2, a very-low protein-controlled diet providing 0.3 g to 0.5 g dietary protein per kg of body weight per day with addition of keto acid analogs to meet protein requirements may be recommended. International studies report that additional keto acid analogs and vitamin or mineral supplementation are needed to maintain adequate nutrition status for patients with CKD who consume a very-low-protein controlled diet (0.3 g to 0.5 g per kg per day).
Strong, Conditional
CKD: Protein Intake for Diabetic Nephropathy
For adults with diabetic nephropathy, the RD should recommend or prescribe a protein-controlled diet providing 0.8 g to 0.9 g of protein per kg of body weight per day. Providing dietary protein at a level of 0.7 g per kg of body weight per day may result in hypoalbuminemia. Research reports that protein-restricted diets improved microalbuminuria.
Fair, Conditional
CKD: Protein Intake for Kidney Transplant
For adult kidney transplant recipients (after surgical recovery, with an adequately functioning allograft), the RD should recommend 0.8 g to 1.0 g per kg of body weight per day for protein intake, addressing specific issues as needed. Adequate, but not excessive, protein intake supports allograft survival and minimizes impact on comorbid conditions.
Consensus, Conditional
Recommendation Strength Rationale
- For the CKD: Protein Intake (Non-dialysis) for eGFR <50 ml per minute per 1.73m2 recommendation, the conclusion statement was Grade I.
- For the CKD: Very-Low-Protein Intake (Non-dialysis) for eGFR <20 ml per minute per 1.73m2 recommendation, the conclusion statement was Grade I.
- For the CKD: Protein Intake for Diabetic Nephropathy recommendation, the conclusion statement was Grade II.
- For the CKD: Protein Intake for Kidney Transplant recommendation, the conclusion statement was Grade III.
CKD Energy Intake
CKD: Energy Intake
For adults with CKD (including post kidney transplant after surgical recovery), the RD should recommend or prescribe an energy intake between 23 kcal to 35 kcal per kg of body weight per day, based on the following factors:
- Weight status and goals
- Age and gender
- Level of physical activity
- Metabolic stressors
Research reports that energy intakes between 23 kcal to 35 kcal per kg body weight per day are adequate to prevent signs of malnutrition.
Fair, Imperative
Recommendation Strength Rationale
- Conclusion statement in support of this recommendation was Grade II.
- The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.
CKD Phosphorus
CKD: Phosphorus
For adults with CKD (Stages Three to Five), the RD should recommend or prescribe a low-phosphorus diet providing 800 mg to 1,000 mg per day or 10 mg to 12 mg phosphorus per gram of protein. CKD patients have a predisposition for mineral and bone disorders. Phosphorus control is the cornerstone for the treatment and prevention of secondary hyperparathyroidism, renal bone disease and soft tissue calcification.
Strong, Conditional
CKD: Adjust Phosphate Binders
For adults with CKD (Stages Three to Five), the dose and timing of phosphate binders should be individually adjusted to the phosphate content of meals and snacks to achieve desired serum phosphorus levels. Serum phosphorus levels are difficult to control with dietary restrictions alone.
Strong, Conditional
CKD: Phosphorus Management for Kidney Transplant
For adult kidney transplant recipients exhibiting hypophosphatemia, the RD should recommend or prescribe a high-phosphorus intake (diet or supplements) to replete serum phosphorus as needed. Hypophosphatemia is common post kidney transplant.
Consensus, Conditional
Recommendation Strength Rationale
- Conclusion statement was Grade II.
- The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease.
CKD Calcium
CKD: Calcium
For adults with CKD (Stages Three to Five, including post kidney transplant), the RD should recommend a total elemental calcium intake (including dietary calcium, calcium supplementation and calcium-based phosphate binders) not exceeding 2, 000 mg per day. CKD patients have a predisposition for mineral and bone disorders. Serum calcium concentration is the most important factor regulating parathyroid hormone (PTH) secretion affecting bone integrity and soft tissue calcification.
Consensus, Conditional
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease.
CKD Vitamin D Therapy
CKD: Vitamin D Supplementation
In adults with CKD (including post kidney transplant), the RD should recommend vitamin D supplementation to maintain adequate levels of vitamin D if the serum level of 25-hydroxyvitamin D is less than 30 ng per ml (75 nmol per L). CKD patients have a predisposition for mineral and bone disorders, as well as other conditions that may be affected by insufficient vitamin D. Sufficient vitamin D should be recommended to maintain adequate levels of serum vitamin D.
Consensus, Conditional
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease.
CKD Anemia
CKD: Iron Supplementation
In adults with CKD (including post kidney transplant), the RD should recommend oral or intravenous (IV) iron administration if serum ferritin is below 100 ng per ml and transferrin saturation (TSAT) is below 20%. CKD patients have a predisposition for anemia. Sufficient iron should be recommended to maintain adequate levels of serum iron to support erythropoiesis.
Consensus, Conditional
CKD: Vitamin B12 and Folic Acid for Anemia
In adults with CKD (including post kidney transplant), the RD should recommend vitamin B12 and folic acid supplementation if the mean corpuscular volume (MCV) is over 100 ng per ml and serum levels of these nutrients are below normal values. CKD patients have a predisposition for anemia and all potential causes should be investigated.
Consensus, Conditional
CKD: Vitamin C for Treatment of Anemia
If the use of vitamin C supplementation is proposed as a method to improve iron absorption for adults with CKD (including post kidney transplant) who are anemic, the RD should recommend the dietary reference intakes (DRI) for vitamin C. There is insufficient evidence to recommend the use of vitamin C supplementation above the DRI in the management of anemia in patients with CKD, due to risk of hyperoxalosis.
Consensus, Conditional
CKD: L-Carnitine for Treatment of Anemia
For adults with CKD (including post kidney transplant) who are anemic, the RD should not recommend L-carnitine supplementation. There is insufficient evidence to recommend the use of L-carnitine in the management of anemia in adults with CKD including post kidney transplant.
Consensus, Conditional
Recommendation Strength Rationale
- Conclusion statement was Grade II.
- The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Anemia in Chronic Kidney Disease.
CKD Management of Hyperglycemia in Diabetes and CKD
CKD: Management of Hyperglycemia in Diabetes and CKD
For adults with diabetes and CKD (including post kidney transplant), the RD should implement MNT for diabetes care to manage hyperglycemia to achieve a target A1C of approximately 7%. Intensive treatment of hyperglycemia, while avoiding hypoglycemia, prevents diabetic kidney disease (DKD) and may slow progression of established kidney disease.
Strong, Conditional
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.
CKD Multi-Faceted Approach to Intervention in Diabetes and CKD
CKD: Multi-Faceted Approach to Intervention in Diabetes and CKD
For adults with diabetes and CKD (including post kidney transplant), the RD should implement MNT using a multi-faceted approach, including education and counseling in healthy behaviors, treatment to reduce risk factors and self-management strategies. Multiple risk factors are managed concurrently in adults with diabetes and CKD and the incremental effects of treating each of these risk factors results in substantial clinical benefits.
Consensus, Conditional
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.
CKD Multi-Faceted Approach to Intervention in Dyslipidemias and CKD
CKD: Multi-Faceted Approach to Intervention in Dyslipidemias and CKD
For adults with dyslipidemia and CKD (including post kidney transplant), the RD should implement MNT, using a multi-faceted approach, including education and counseling in therapeutic lifestyle changes (TLC), treatment to reduce risk factors and self-management strategies. Multiple risk factors are managed concurrently in adults with dyslipidemia and CKD and the incremental effects of treating each of these risk factors results in substantial clinical benefits.
Fair, Conditional
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for:
- Managing Dyslipidemias in Chronic Kidney Disease
- Diabetes and Chronic Kidney Disease
CKD Education on Self-Management Behaviors
CKD: Education on Self-Management Behaviors
For individuals with CKD (including post kidney transplant), the RD should provide education and counseling regarding self-management behaviors. Therapy must take into consideration the patient's perception of the health-care provider's advice and prescriptions, factors that may influence self-management behaviors and the likelihood that the patient will adhere to recommendations.
Fair, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease.
CKD Sodium
CKD: Control Sodium Intake in CKD
For adults with CKD (including post-kidney transplant) the RD should recommend/prescribe a sodium intake of less than 2.4 g (Stages One to Five), with adjustments based on the following:
- Blood pressure
- Medications
- Kidney function
- Hydration status
- Acidosis
- Glycemic control
- Catabolism
- Gastrointestinal issues, including vomiting, diarrhea and constipation
Dietary and other therapeutic lifestyle modifications are recommended as part of a comprehensive strategy to reduce cardiovascular disease risk in adults with CKD.
Fair, Imperative
Recommendation Strength Rationale
- Conclusion statement received Grade II.
- The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease and the Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.
CKD Fish Oil/Omega-3 Fatty Acids
CKD: Fish Oil/Omega-3 Fatty Acids
If the use of fish oil or omega-3 fatty acid supplementation is proposed as a method to improve renal function, the RD should advise on the conflicting evidence regarding effectiveness of this strategy. Research reports that renal outcomes were inconsistent among patients with immunoglobulin A (IgA) nephropathy who received fish oil supplementation. There is insufficient evidence to support fish oil therapy to improve renal function and patient or graft survival for kidney transplant patients. However, evidence does support a benefit of fish oil supplementation in reducing oxidative stress and improving lipid profile in adults with CKD (including post kidney transplant).
Fair, Conditional
Recommendation Strength Rationale
Conclusion statements were Grades II and III.
CKD Physical Activity
CKD: Physical Activity
If not contraindicated, the RD should encourage adults with CKD (including post kidney transplant), to increase frequency or duration of physical activity as tolerated. Studies report that physical activity may minimize the catabolic effects of protein restriction and improve quality of life.
Fair, Conditional
Recommendation Strength Rationale
Conclusion statements were Grade III.
CKD Coordination of Care
CKD: Coordination of Care
For adults with CKD (including post kidney transplant), the RD should implement MNT and coordinate care with an interdisciplinary team, through:
- Requesting appropriate data (biochemical and other)
- Communicating with referring provider
- Indicating specific areas of concern or needed reinforcement.
This approach is necessary to effectively integrate MNT into overall management for patients with CKD.
Consensus, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.
CKD Multivitamin Supplementation
CKD: Multivitamin Supplementation
In adults with CKD (including post kidney transplant), with no known nutrient deficiency (biochemical or physical) and who may be at higher nutritional risk due to poor dietary intake and decreasing GFR, the RD should recommend or prescribe a multivitamin preparation. Sufficient vitamin supplementation should be recommended to maintain indices of adequate nutritional status.
Consensus, Conditional
Recommendation Strength Rationale
- Conclusion statement was Grade III.
- The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease.
CKD Potassium
CKD: Control Potassium Intake in CKD
For adults with CKD (including post kidney transplant) who exhibit hyperkalemia, the RD should recommend or prescribe a potassium intake of less than 2.4 g (Stages Three to Five), with adjustments based on the following:
- Serum potassium level
- Blood pressure
- Medications
- Kidney function
- Hydration status
- Acidosis
- Glycemic control
- Catabolism
- Gastrointestinal (GI) issues, including vomiting, diarrhea, constipation and GI bleed
Dietary and other therapeutic lifestyle modifications are recommended as part of a comprehensive strategy to reduce cardiovascular disease risk in adults with CKD. The degree of hypokalemia or hyperkalemia can have a direct effect on cardiac function, with potential for cardiac arrhythmia and sudden death.
Fair, Conditional
Recommendation Strength Rationale
- Conclusion statement was Grade II.
- The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease and the Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.
CKD Monitor and Evaluate Biochemical Parameters
CKD: Monitor and Evaluate Biochemical Parameters
The RD should monitor and evaluate various biochemical parameters in adults with CKD (including post kidney transplant), related to:
- Glycemic control
- Protein-energy malnutrition
- Inflammation
- Kidney function
- Mineral and bone disorders
- Anemia
- Dyslipidemia
- Electrolyte disorders
- Others as appropriate
Monitoring and evaluation of the above factors is needed to determine the effectiveness of MNT in adults with CKD and post kidney transplant.
Consensus, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for:
- Nutrition in Chronic Renal Failure
- Bone Metabolism and Disease in Chronic Kidney Disease
- Anemia in Chronic Kidney Disease
CKD Monitor and Evaluate Adherence to Nutrition and Lifestyle Recommendations
CKD: Monitor and Evaluate Adherence to Nutrition and Lifestyle Recommendations
The RD should monitor the following in adults with CKD (including post kidney transplant):
- Food and nutrient intake (e.g., diet history, diet experience and intake of macronutrients and micronutrients, such as energy, protein, sodium, potassium, calcium, phosphorus and others, as appropriate)
- Medication (prescription and over-the-counter), dietary supplements (vitamin, minerals, protein, etc.), herbal or botanical supplement use
- Knowledge, beliefs or attitudes (e.g., readiness to change nutrition and lifestyle behaviors)
- Behavior
- Factors affecting access to food and food- and nutrition-related supplies (e.g., safe food and meal availability)
Monitoring and evaluation of the above factors is needed to determine the effectiveness of MNT in adults with CKD and post kidney transplant.
Consensus, Imperative
Recommendation Strength Rationale
The ADA CKD Expert Work Group concurs with the National Kidney Foundation KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.
Definitions:
Conditional versus Imperative Recommendations
Recommendations can be worded as conditional or imperative statements. Conditional statements clearly define a specific situation, while imperative statements are broadly applicable to the target population without restraints on their pertinence. More specifically, a conditional recommendation can be stated in if/then terminology (e.g., If an individual does not eat food sources of omega-3 fatty acids, then 1g of EPA and DHA omega-3 fatty acid supplements may be recommended for secondary prevention).
In contrast, imperative recommendations "require," or "must," or "should achieve certain goals," but do not contain conditional text that would limit their applicability to specified circumstances. (e.g., Portion control should be included as part of a comprehensive weight management program. Portion control at meals and snacks results in reduced energy intake and weight loss).
Conclusion Grading Table
Strength of Evidence Elements |
Grade I
Good/Strong |
Grade II
Fair |
Grade III
Limited/Weak |
Grade IV
Expert Opinion Only |
Grade V
Grade Not Assignable |
Quality
- Scientific rigor/validity
- Considers design and execution
|
Studies of strong design for question
Free from design flaws, bias and execution problems |
Studies of strong design for question with minor methodological concerns
OR
Only studies of weaker study design for question |
Studies of weak design for answering the question
OR
Inconclusive findings due to design flaws, bias or execution problems |
No studies available
Conclusion based on usual practice, expert consensus, clinical experience, opinion, or extrapolation from basic research |
No evidence that pertains to question being addressed |
Consistency
Of findings across studies |
Findings generally consistent in direction and size of effect or degree of association, and statistical significance with minor exceptions at most |
Inconsistency among results of studies with strong design
OR
Consistency with minor exceptions across studies of weaker designs |
Unexplained inconsistency among results from different studies
OR
Single study unconfirmed by other studies |
Conclusion supported solely by statements of informed nutrition or medical commentators |
NA |
Quantity
- Number of studies
- Number of subjects in studies
|
One to several good quality studies
Large number of subjects studied
Studies with negative results having sufficiently large sample size for adequate statistical power |
Several studies by independent investigators
Doubts about adequacy of sample size to avoid Type I and Type II error |
Limited number of studies
Low number of subjects studied and/or inadequate sample size within studies |
Unsubstantiated by published studies |
Relevant studies have not been done |
Clinical Impact
- Importance of studies outcomes
- Magnitude of effect
|
Studied outcome relates directly to the question
Size of effect is clinically meaningful
Significant (statistical) difference is large |
Some doubt about the statistical or clinical significance of effect |
Studied outcome is an intermediate outcome or surrogate for the true outcome of interest
OR
Size of effect is small or lacks statistical and/or clinical significance |
Objective data unavailable |
Indicates area for future research |
Generalizability
To population of interest |
Studied population, intervention and outcomes are free from serious doubts about generalizability |
Minor doubts about generalizability |
Serious doubts about generalizability due to narrow or different study population, intervention or outcomes studied |
Generalizability limited to scope of experience |
NA |
This grading system was based on the grading system from: Greer N, Mosser G, Logan G, Wagstrom Halaas G. A practical approach to evidence grading. Jt Comm. J Qual Improv. 2000; 26:700-712. In September 2004, The ADA Research Committee modified the grading system to this current version.
Criteria for Recommendation Rating
Statement Rating |
Definition |
Implication for Practice |
Strong |
A Strong recommendation means that the workgroup believes that the benefits of the recommended approach clearly exceed the harms (or that the harms clearly exceed the benefits in the case of a strong negative recommendation), and that the quality of the supporting evidence is excellent/good (grade I or II).* In some clearly identified circumstances, strong recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits strongly outweigh the harms. |
Practitioners should follow a Strong recommendation unless a clear and compelling rationale for an alternative approach is present. |
Fair |
A Fair recommendation means that the workgroup believes that the benefits exceed the harms (or that the harms clearly exceed the benefits in the case of a negative recommendation), but the quality of evidence is not as strong (grade II or III).* In some clearly identified circumstances, recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits outweigh the harms. |
Practitioners should generally follow a Fair recommendation but remain alert to new information and be sensitive to patient preferences. |
Weak |
A Weak recommendation means that the quality of evidence that exists is suspect or that well-done studies (grade I, II, or III)* show little clear advantage to one approach versus another. |
Practitioners should be cautious in deciding whether to follow a recommendation classified as Weak, and should exercise judgment and be alert to emerging publications that report evidence. Patient preference should have a substantial influencing role. |
Consensus |
A Consensus recommendation means that Expert opinion (grade IV)* supports the guideline recommendation even though the available scientific evidence did not present consistent results, or controlled trials were lacking. |
Practitioners should be flexible in deciding whether to follow a recommendation classified as Consensus, although they may set boundaries on alternatives. Patient preference should have a substantial influencing role. |
Insufficient Evidence |
An Insufficient Evidence recommendation means that there is both a lack of pertinent evidence (grade V)* and/or an unclear balance between benefits and harms. |
Practitioners should feel little constraint in deciding whether to follow a recommendation labeled as Insufficient Evidence and should exercise judgment and be alert to emerging publications that report evidence that clarifies the balance of benefit versus harm. Patient preference should have a substantial influencing role. |
*Conclusion statements are assigned a grade based on the strength of the evidence. Grade I is good; grade II, fair; grade III, limited; grade IV signifies expert opinion only and grade V indicates that a grade is not assignable because there is no evidence to support or refute the conclusion. The evidence and these grades are considered when assigning a rating (Strong, Fair, Weak, Consensus, Insufficient Evidence - see chart above) to a recommendation.
Adapted by the American Dietetic Association from the American Academy of Pediatrics, Classifying Recommendations for Clinical Practice Guideline, Pediatrics. 2004;114;874-877.